MLOCT.PA PAR
Octopus Biosafety S.A.
1W: +6.6%
1M: +16.0%
3M: -21.6%
YTD: -21.6%
1Y: -27.5%
3Y: -64.6%
5Y: -86.8%
€0.14 ($0.16)
-0.01 (-7.05%)
Weekly Expected Move ±17.8%
€0
€0
€0
€0
€0
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Income Trends
Revenue
$52K
-77.2% ▼
5Y CAGR: +32.2%
Gross Profit
-$336K
-380.8% ▼
Operating Income
-$837K
+41.8% ▲
Net Income
-$659K
+62.9% ▲
EPS (Diluted)
$-0.04
+63.3% ▲
EBITDA
-$155K
+87.0% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $223K | $67K | $22K | $229K | $52K |
| YoY Growth | +1626.0% | -70.1% | -67.4% | +952.0% | -77.2% |
| Cost of Revenue | $2M | $1M | $77K | $299K | $389K |
| Gross Profit | -$1M | -$1M | -$55K | -$70K | -$336K |
| Gross Margin | -613.6% | -1650.3% | -252.9% | -30.5% | -642.9% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $21K | $12K | $0 | $0 | $0 |
| Operating Expenses | $1M | $1M | $671K | $1M | $501K |
| Operating Income | -$1M | -$1M | -$735K | -$1M | -$837K |
| Operating Margin | -627.4% | -1699.1% | -3372.6% | -627.1% | -1601.1% |
| Interest Expense | $9K | $9K | $5K | $3K | $1K |
| Income Before Tax | -$1M | -$1M | -$960K | -$1M | -$839K |
| Tax Expense | -$230K | -$246K | -$157K | $191K | -$209K |
| Net Income | -$832K | -$1M | -$803K | -$2M | -$659K |
| Net Margin | -372.5% | -1512.4% | -3682.1% | -774.8% | -1260.0% |
| EPS (Diluted) | $-0.20 | $-0.25 | $-0.20 | $-0.12 | $-0.04 |
| EBITDA | -$576K | -$754K | -$486K | -$1M | -$155K |
| Shares Outstanding | 4M | 4M | 4M | 15M | 15M |